A Vaccine by November? Science Journalist in Vaccine Trial Casts Doubt on Rosy U.S. Projections
With 30,000 people taking part in the first major COVID-19 vaccine study in the United States, hopes are high that the collaboration between drugmaker Moderna and the National Institutes of Health will yield positive results as early as November. Researchers around the world are working on more than 165 vaccine candidates, though only a handful are conducting large-scale human trials.